Register Early To Save
Enrol before 15 November to save 20% (December Course)
Discount has been applied to the price above. VAT, if applicable, will be added.
£295.00 Original price was: £295.00.£236.00Current price is: £236.00.
1 day live online training | Starts 10 AM UK Time
Are you new to Cell and Gene therapies? Do you work in a non-technical role? Understand the basics of cell and gene therapies to support you in your role.
Discount has been applied to the price above. VAT, if applicable, will be added.
Learn more about the course by toggling through the tabs below. Scroll down to view the agenda, trainer info and who should attend.
Scientific advances have led to a new generation of innovative therapeutic products. These new therapeutics are called many things: cell therapies, stem cell therapies, CAR-T, gene therapies, advanced therapies, Advanced Therapeutic Medicinal Products (AMTPs). This new and exciting areas of treatments are growing year on year. But what are they? What makes them so effective? What makes them so expensive? How are they different from biopharmaceuticals and pharmaceuticals?
This training course will provide you with a comprehensive overview of how cell and gene therapies products are developed and manufactured. The course is designed for professionals who require a basic understanding of the science and technology. Once completed, you will understand what each advanced therapy is, how it is made and the challenges that must be overcome. You will also appreciate the major challenges of developing and manufacturing an ATMP including regulatory, clinical and quality issues.
You can view the agenda by scrolling down on this page. If you would like to receive a PDF version with all the course information, please complete the form below.
Find out when this course is running so you can plan your training. Scroll down to view the full agenda.
1-Day Live Online Training
Register at the top of the page.
1-Day Live Online Training
Register at the top of the page.
1-Day Live Online Training
Register at the top of the page.
1-Day Live Online Training
Register at the top of the page.
1-Day Live Online Training
Register at the top of the page.
If you want to train a small group, we offer a group discount between 5% and 50% depending on the course and number of attendees.
For a quote, complete our contact form by following the link. Get in touch.
We also design and deliver fully customised team training focused on your products, processes, technologies and challenges. This is ideal for specific training requirements or larger groups. Please get in touch with us for more information.
For more information, complete our contact form by following the link. Get in touch.
Learn more about the course by toggling through the tabs below (Agenda, Trainer and Who Should Attend?)
Course Information
3 December 2024
12 March 2025
5 June 2025
11 September 2025
120 mins | 10:00 AM UK
Module 1: Introduction to the CGT industry
Module 2: Examine the science of CGTs
This module will provide you with an overview of how biopharmaceuticals are made and how their quality is ensured. Â This will then be brought into perspective to the novel CGTs and highlight some fundamental differences in the approach to development and manufacture these unique products.
3 December 2024
12 March 2025
5 June 2025
11 September 2025
120 mins | 1:00 PM UK
Module 3: The CGT manufacturing process
Now you know the science behind CGTs, this module will examine the manufacturing process from start to finish for selected products such as cell therapy and CAR T cells.
Module 4: Examine major challenges during CGT development and manufacturing
In this module you will examine some of the major challenges faced by companies when developing CGT product such as manufacturing facilities, regulatory problems and bioanalytical issues.
Dr. Melody Janssen is an expert in bioanalysis and immunogenicity testing of biopharmaceuticals with in-depth experience as a project manager, trainer and senior expert in biotech/CGT companies. She has worked on numerous biopharmaceutical products and is an expert on all areas of biopharmaceutical development and manufacturing.
Dr. Janssen has extensive experience of the regulatory frameworks (EMA, FDA etc.) for biopharmaceutical development/manufacturing. Ultimately Melody is aware of the many challenges biopharmaceutical companies face when developing a therapeutic product.
She is frequently invited to speak at conferences on immunogenicity and bioanalytical testing, where she also leads conference specific workshops and seminars. She has shared her knowledge through trainings for over 10 years focusing on assay validation for bioanalytical, potency and immunogenicity assays.
For the last years, Dr. Janssen has been working as a freelancer for projects including non-clinical and clinical immunogenicity assessment, leading various late pre-clinical candidates to FIH, production of vaccines and biologics and teaching bioanalytical method validation workshops.
Her educational background is in infectious diseases and immunology, with a PhD in pharmaceutical sciences investigating the effect of protein aggregates on immunogenicity.
This course is specifically designed for professionals who are not technical experts but wish to have a high level understanding of cell and gene therapies. It is also ideal for technical professionals who are new to cell and gene therapies. It will provide you with comprehensive overview of the sector to support you in your job.
Sectors and job roles this course is most suited for include:
Pfizer Ltd (verified owner) –
n/a
Pharmaplan (verified owner) –
n/a
Benchling (verified owner) –
It was a really good overview and now I can tailor my attention and focus on the gene and cell therapy processes that I want to dive into.
Roche Products –
n/a
Health Canada (verified owner) –
n/a
Gilead (verified owner) –
.
AmplifyBio –
n/a
Danish Medicines Agency (verified owner) –
n/a
Halmed (Hungarian Agency) (verified owner) –
Presented in a very interesting manner, all relevant details provided.
Eppendorf (verified owner) –
In my role as Regulatory Affairs Manager, I needed to gain a better understanding of the CGT field as well as challenges faced by our CGT customers to determine expectations for Quality and Regulatory requirements related to equipment. The course presented vital information and I was pleasantly surprised at the volume of information as well as the ability of the presenter to communicate complex scientific information in an understandable manner for a non-scientist.